Yibing Qyang is a Professor of Medicine (Cardiovascular Medicine) at Yale University School of Medicine (YSM), affiliated with the Department of Internal Medicine. He serves as Director of the Yale Stem Cell Research Forum since 2010. His expertise spans stem cell biology, cardiovascular disease modeling, and regenerative medicine. Qyang holds a B.S. from Nanjing University, an M.S. from Chinese Academy of Sciences, and a Ph.D. from the University of Texas M.D. Anderson Cancer Center. He completed postdoctoral training at UC San Diego and Harvard Medical School. Research Interests: The Qyang Lab focuses on engineering vascular tissues using induced pluripotent stem cells (iPSCs), elucidating cardiovascular disease mechanisms, and developing therapeutic strategies. Key areas include: Vascular tissue engineering for graft development Stem cell-derived models of diseases like supravalvular aortic stenosis Cardiac progenitor cell therapies for heart repair Biomechanical signaling in hypertrophic cardiomyopathy Preclinical porcine models for translational research Key Achievements: Developed immunocompatible 'universal donor' vascular grafts using CRISPR-engineered iPSCs Pioneered iPSC-derived vascular smooth muscle and endothelial cells for tissue engineering Identified elastin-based therapies for supravalvular aortic stenosis Grants & Awards: Connecticut Stem Cell Program Established Investigator Awards (2011, 2015) ISSCR Membership (2007–Present) Highlighted in Yale News for groundbreaking discoveries in heart disease and vascular grafts Lab Team & Collaborations: The lab includes researchers and students from institutions worldwide, with collaborations at Harvard, UCSD, and Yale’s Cardiovascular Research Center. Projects span iPSC differentiation, biomechanical modeling, and preclinical trials. Future Directions: Expanding studies on universal donor grafts, cardiac tissue engineering, and clinical translation of iPSC-derived therapies.
Professor Siobhán McClean (University College Dublin) is a leading researcher in Biomolecular and Biomedical Science with 24 years of academic experience. Her work focuses on chronic respiratory infections in cystic fibrosis patients and vaccine development against ESKAPE pathogens. Current roles: Professor (2024-present) Associate Dean for Widening Participation (2019-2023) Head of Biochemistry (2019-2022) Academic qualifications: BSc in Biochemistry, UCD PhD, Imperial College London Professional Diploma in Creativity & Innovation, UCD Research Interests: Specializing in bacterial adaptation to hypoxia in chronic infections, she leads studies on Burkholderia cepacia complex, Pseudomonas aeruginosa, and Pandoraea pulmonicola. Her team develops novel vaccine antigens through proteomic analysis of host-pathogen interactions, with recent work on TLR4 agonists and universal stress proteins. Article Trends: Recent publications focus on mRNA vaccine platforms, hypoxia-driven pathogenesis, and cross-reactive antigens for ESKAPE pathogens. Key themes include adjuvant optimization, host cell attachment mechanisms, and immune correlate analysis across bacterial/viral/parasitic agents. Scientific Awards: Principal Investigator for Marie Curie BactiVax network Coordinator of All-island Vaccine Research Alliance (AIVRT) Science Foundation Ireland grant recipient Training Leadership: Supervises 7 active PhD researchers and has trained 15 Marie Curie students across 8 countries. Her lab develops cationic nanoparticles and investigates bacterial stress responses.
Dr. Yoshimi Fukuoka is a Professor at the University of California, San Francisco (UCSF) School of Nursing , specializing in Physiological Nursing . She holds a PhD in Nursing and Postdoctoral Fellowship from UCSF, with a career focused on AI-driven health interventions , chronic disease prevention , and mobile health (mHealth) applications for diverse populations. Her research bridges artificial intelligence and behavioral health , emphasizing personalized physical activity programs , cardiovascular risk reduction , and diabetes prevention . She has developed AI chatbots to improve heart disease awareness and conducted clinical trials on metabolic syndrome and colorectal cancer survivorship . Recent publications highlight her work on: AI chatbots for heart attack knowledge and physical activity interventions Machine learning in diabetes risk prediction and microRNA analysis Cultural adaptations of mHealth for Asian Americans and Latinos Behavioral analytics in weight loss and exercise adherence Scientific awards include: 2014-2017: National Science Foundation EAGER Grant 2011-2013: UCSF Diabetes Family Fund Award 2010-2012: American Heart Association National Clinical Research Program Award 2008: Marie Cowan Promising Young Investigator Award Her work spans UCSF , with collaborations across NIH , Alzheimer's Association , and Noyce Foundation , addressing health disparities , digital health policy , and precision health through grants like NIH R01HL104147 and K24NR015812 . Media coverage includes USA Today , NHLBI News , and UCSF News for her AI in nursing innovations.
Tiffany A. Radcliff, PhD , is Professor of Health Policy & Management in the Texas A&M University School of Public Health and concurrently serves as the Senior Associate Dean for Research . In this dual role she guides the school’s strategic research agenda while maintaining an active, federally funded research portfolio. Education PhD, Health Services Research, Policy & Administration – University of Minnesota BS (Magna Cum Laude), Economics; Minor, Political Science – Texas A&M University Research Interests Radcliff’s work lies at the intersection of health economics , health policy , and health-services research . Her overarching goal is to improve the quality, accessibility, and affordability of care—particularly for rural and underserved populations . Current emphases include: Economic evaluation of behavioral interventions for obesity and diabetes in rural settings Post-acute care transitions and long-term care quality Industrial organization of healthcare markets and provider responses to policy Disaster preparedness and health-system resilience Publication Trends Across 200+ peer-reviewed articles spanning 1997–2025, Radcliff’s scholarship shows a clear evolution from foundational work on rural hospital markets to large-scale comparative-effectiveness and implementation-science studies. Recent clusters (2020–2025) focus on COVID-19 policy impacts, telehealth cost-effectiveness, and VA transitional-care programs, reflecting a sustained commitment to policy-relevant, methodologically rigorous research. Scientific Awards & Honors (No specific awards listed in the provided text; extensive federal funding and invited lectureships implied by CV and publication record.) Grants & Advising Principal or Co-Investigator on multiple NIH, AHRQ, and VA Health Services Research & Development grants Faculty mentor for PhD, MPH, and post-doctoral trainees in health policy, economics, and implementation science Serves on dissertation and thesis committees for students across Texas A&M and collaborating institutions Labs & Teams Radcliff leads an active research group of graduate research assistants, post-docs, and biostatisticians housed within the Center for Health Organization Transformation (CHOT) and collaborates closely with the VA Health Services Research Center of Innovation and the Southwest Rural Health Research Center at Texas A&M.
Dr. Karen Birkenhead is a Postdoctoral Research Fellow in Implementation Science at the Sydney School of Health Sciences, University of Sydney. She holds a PhD in Human Movement (2018) and a Master of Sports Nutrition by Research (2014). Her research focuses on cardiovascular diseases, nutrition, exercise physiology, and genetic medicine, with a current project implementing a shared care model for familial hypercholesterolemia (FH). She previously worked as a Registered Dietitian in Canada for 14 years, specializing in public health, sports nutrition, telehealth, and chronic disease management. Education: PhD in Human Movement, 2018 Masters in Sports Nutrition, 2014 Her research themes include Obesity, Diabetes and Cardiovascular Disease, Healthy Ageing, and Lifespan Health. Key projects include translational research grants for FH care models and perioperative nutrition strategies. She has received awards such as the HDR Student Research Grant (2015) and the USCIRS (2014). Dr. Birkenhead collaborates with organizations like the Nutrition Society of Australia and Professionals in Nutrition for Exercise and Sport. Her work bridges clinical practice and research, aiming to improve patient outcomes through evidence-based interventions.
Professor Banu Bayar is a distinguished faculty member at Muğla Sıtkı Koçman University's Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation with specialization in Musculoskeletal Rehabilitation. With over two decades of academic and clinical experience, she has established herself as a leading researcher in physical therapy and rehabilitation sciences. Education: Bachelor's Degree: Hacettepe University - School of Physical Therapy and Rehabilitation (1990-1994) Master's Degree: Hacettepe University - Institute of Health Sciences - Physical Therapy and Rehabilitation (MSc) (1996-1998) Doctorate: Hacettepe University - Institute of Health Sciences - Physical Therapy and Rehabilitation (1998-2002) Professor Bayar's research spans multiple critical areas in rehabilitation science, with particular emphasis on stroke rehabilitation, musculoskeletal disorders, pain management, and geriatric rehabilitation. Her work integrates clinical practice with scientific research to develop evidence-based rehabilitation protocols. She has extensively studied proprioception, balance disorders, and functional recovery in neurological conditions, contributing significantly to the understanding of how physical interventions can improve patient outcomes. Her publication record demonstrates consistent scholarly output with a notable increase in high-impact research in recent years. The trend shows a strategic focus on developing assessment tools, validating measurement instruments, and investigating innovative rehabilitation techniques. Her work bridges clinical practice and scientific validation, with particular attention to culturally adapted assessment tools for the Turkish population. Recent publications reveal growing interest in technology-assisted rehabilitation, cognitive-motor interactions, and the psychological aspects of chronic conditions. Professor Bayar has served as an editor for multiple journals including the Journal of Karya Health Science (2020-2022) and has contributed to numerous book chapters on physiotherapy and rehabilitation. Her collaborative research approach is evident in her extensive co-authorship network, working with colleagues across various institutions to advance rehabilitation science. While specific grant information isn't detailed in the available records, her sustained publication output suggests successful research funding throughout her career.
Sunita Mathur is an Associate Professor in the School of Rehabilitation Therapy at Queen's University, affiliated with the Faculty of Health Sciences. She holds a cross-appointment as Associate Director of the School of Rehabilitation Therapy. Her research focuses on improving skeletal muscle function in chronic diseases, including COPD, cystic fibrosis, and critical illness, using non-invasive techniques like MRI, ultrasound, and dynamometry. She co-founded CAN-RESTORE to promote exercise in solid organ transplant recipients and leads the Canadian Donation and Transplantation Research Program (CDTRP) Theme 5. Education: BSc Physiotherapy (Dalhousie University), MSc Rehabilitation (Dalhousie), PhD Human Kinetics (University of British Columbia), and a postdoc at the University of Florida. She supervises students in AGHE PhD and RHBS MSc/PhD programs. Research interests span sarcopenia, muscle dysfunction in chronic illness, and rehabilitation strategies. Her work integrates clinical and translational approaches to enhance patient outcomes through tailored exercise programs and advanced imaging. Key contributions include studies on ICU-acquired weakness, lung transplant rehabilitation, and the role of exercise in improving post-transplant outcomes. She has collaborated on international initiatives like the RECOVER Program to address long-term outcomes of critical illness survivors.
Christopher Grainge is a Conjoint Associate Professor at the University of Newcastle's School of Medicine and Public Health, and a Staff Specialist in Respiratory and General Medicine at John Hunter Hospital. Previously, he served as a Consultant Physician and Senior Lecturer at the University of Southampton. His extensive clinical background includes service in the Royal Navy, specializing in diving and remote medicine, and deployments to Antarctica and Southern Iraq. Dr. Grainge maintains active research collaborations with institutions worldwide, focusing on respiratory medicine. Dr. Grainge completed his undergraduate training at Imperial College, University of London, with an intercalated BSc. He earned his PhD from the University of Southampton in 2011, with research published in the New England Journal of Medicine. His thesis examined the effect of repeated bronchoconstriction on airways in asthma. He also holds membership in the Royal College of Physicians and was awarded the Diploma in the Medical Care of Catastrophes, specializing in remote and refugee medicine. Dr. Grainge's research focuses on the role of mechanical forces in asthma pathophysiology, environmental dusts in lung disease development, and platelet antagonists' effects on allergen challenge. His work demonstrates that mechanical forces play a crucial role in determining long-term changes in human airways. He leads investigations into how environmental exposure to inhaled particles leads to conditions like constrictive bronchiolitis, and explores novel therapeutic pathways for asthma through platelet activation inhibition. His research has significant clinical implications for difficult asthma and interstitial lung disease management. Dr. Grainge's recent publications reflect strong trends in interstitial lung disease research, particularly idiopathic pulmonary fibrosis, and asthma mechanisms. His work increasingly incorporates advanced technologies like artificial intelligence for disease stratification and deep learning for predicting disease progression. Collaborative research with international teams examines biomarkers for disease progression and novel treatment approaches for fibrotic lung diseases, with a particular focus on quantitative CT analysis and patient-reported outcome measures. Leatherdale Prize for Clinical Teaching: Finalist (2013) Military and Civilian Health Partnership Awards Winner (2011) University of Southampton Translational Medicine Research Prize (2011) Michael Arthur Clinical Research Prize (2014) British Lung Foundation Travel Fellowship (2011) Gilbert Blane Medal (2010) Colt Foundation Prize: Finalist (2010) Asthma UK Travel Fellowship (2009) Dr. Grainge has received significant research funding from the British Lung Foundation, the Southampton Marine and Maritime Institute, the Institute for Life Sciences, and the Gerald Kerkut Foundation. His projects investigate the effects of physical and environmental stress on lung disease, mechanisms underlying lung disease development following environmental particle exposure, and potential therapies. He has collaborated extensively with research teams across Australia, the UK, the Netherlands, and South Africa, contributing to the training of numerous students and junior researchers through his supervision and mentorship roles. Dr. Grainge collaborates extensively with the Respiratory Research group at the University of Southampton, the Asthma and COPD Research Group at the University of Groningen in the Netherlands, and the Microbiome group at the South Australia Medical Research Institute. His current work at the Hunter Medical Research Institute (HMRI) focuses on mechanical forces within airways and their impact on acute and long-term lung changes in patients with airway diseases. He is also involved in the Australian IPF Registry, contributing to multicenter studies on idiopathic pulmonary fibrosis progression and treatment outcomes.
Dr. Cory Smith is an Assistant Professor in the Department of Health, Human Performance, and Recreation at Baylor University, where he directs the Human & Environmental Physiology Laboratory. His applied physiology research focuses on neurophysiological assessment methodologies, extreme environment adaptations, and sensor-based physiological monitoring systems. Current projects examine neuromuscular disease diagnostics, warfighter performance optimization, and cognitive-physiological responses in austere environments through translational research approaches. Primary research interests include: Aerospace/environmental physiology : Investigating human responses to hypoxia, cold, and gravitational stressors Neurophysiological monitoring : Developing fNIRS/EMG methodologies for clinical and tactical applications Sensor data fusion : Integrating multimodal physiological signals for performance assessment Muscle fatigue mechanisms : Studying neuromuscular adaptations during exertion under environmental constraints Analysis of recent publications (2022-2025) reveals dominant themes in neurophysiological monitoring techniques (particularly fNIRS applications), environmental stressor impacts on human performance, and rehabilitation physiology. Research consistently bridges clinical applications (neuromuscular diseases, cerebral palsy) with tactical performance optimization (marksmanship, combat fitness). Methodological innovations in EMG signal processing and hypoxia protocols form significant technical throughlines. Dr. Smith leads a research team collaborating with clinical practitioners to translate physiological insights into practical interventions for military personnel, occupational workers, and clinical populations.
Eva Lindberg is a Professor at the Department of Medical Sciences , Uppsala University , specializing in Lung, Allergy, and Sleep Research . She has contributed extensively to understanding the interplay between sleep-related disorders and respiratory/cardiovascular health. Research Themes : Sleep apnea, COPD, asthma, cardiometabolic risks, population-based studies. Key Collaborations : RHINESSA, SCAPIS, MUSTACHE cohorts. Her 2025 publications focus on cardiovascular consequences of sleep apnea, proteomic associations in lung disease, and cancer risks linked to nocturnal breathing disorders. Earlier work (2024–2022) examines obesity, physical activity, and environmental factors in sleep and respiratory health. Eva Lindberg is actively involved in clinical trials for sleep apnea interventions, including behavioral medicine and device-based therapies. She emphasizes sex-specific differences in sleep disorder diagnosis and outcomes.
Wilson Miller serves as Associate Professor of Radiology and Medical Imaging within the Department of Radiology and Medical Imaging at the University of Virginia School of Medicine. His research bridges advanced medical imaging physics with clinical pulmonary and neurological applications, maintaining active collaborations across radiology, pulmonology, and neurosurgery departments. Dr. Miller's research program centers on two transformative domains: hyperpolarized gas MRI for pulmonary disease characterization and focused ultrasound for neurological interventions. In pulmonary imaging, he pioneers hyperpolarized xenon-129 and helium-3 MRI techniques to map regional lung function in COPD, asthma, and lung transplantation, identifying novel imaging biomarkers for early disease detection and treatment monitoring. His neurological work develops focused ultrasound protocols for blood-brain barrier opening to enhance therapeutic delivery for cerebral cavernous malformations and brain tumors, with recent publications demonstrating lesion regression and improved drug penetration. Analysis of his 2023-2025 publications reveals accelerating integration of molecular techniques with imaging, particularly transcriptomic analysis of rejection in lung transplants and immune response mapping in glioblastoma. His work increasingly emphasizes multimodal assessment combining hyperpolarized gas MRI with histological and molecular validation, while maintaining a secondary research thread in spin-polarized fusion physics for energy applications. Scientific Awards: No specific awards documented in source materials Dr. Miller actively mentors graduate students and postdoctoral researchers within the Medical Imaging PhD program, though individual advisee names were not provided in source texts. His research program likely operates through NIH-funded R01 grants from the National Heart, Lung, and Blood Institute (NHLBI) and National Institute of Neurological Disorders and Stroke (NINDS), supported by collaborative infrastructure from the University of Virginia's Radiology Research Division. His laboratory operates advanced 3T MRI systems with hyperpolarized gas delivery capabilities and preclinical focused ultrasound platforms, collaborating with the UVA Brain Immunology and Glia Center and Lung Repair and Regeneration Consortium. Current projects include developing AI-enhanced analysis of hyperpolarized gas MRI for COPD endotyping and optimizing microbubble parameters for focused ultrasound-mediated drug delivery to brain lesions.
Anne-Sofie Helvik is a Professor at the Norwegian University of Science and Technology (NTNU) within the Department of Public Health and Nursing . Her research focuses on quality of life, coping mechanisms, aging, impairment, and disabilities, with a particular emphasis on older adults. Email: anne-sofie.helvik@ntnu.no Location: Øya Helsehus, 153.03.001, Øya, Håkon Jarls gate 11 Her work spans multiple domains: Health Promotion: Central to her research is improving health outcomes in older populations. Substance Misuse: Investigates alcohol and drug use among older adults and its impact on health. Mental Health: Studies depression, pain, and dementia in aging populations. Sensory Function: Explores olfactory and hearing impairments in older adults. Healthcare Systems: Evaluates treatment, care, and postoperative follow-up in both pediatric and geriatric contexts. Her methodological approach combines both quantitative and qualitative research , with a strong emphasis on longitudinal studies and population-based analyses. Currently, she supervises two doctoral students: Heidi Sivertsen – Researching depression among older community residents. Ingrid Torvik Heian – Investigating olfactory functioning. Her research unit, Allmennmedisinsk Forsknings Enhet (AFE) , focuses on aging and health in older adults, accessible via NTNU’s aging and health page.
Molly S. Shoichet serves as a University Professor at the University of Toronto's Faculty of Applied Science and Engineering, holding the Pamela and Paul Austin Chair in Precision and Regenerative Medicine and previously the Michael E. Charles Chair in Chemical Engineering. She leads the Shoichet Laboratory (Room 514, 160 College Street) focused on biomaterials-driven solutions for regenerative medicine and drug delivery challenges. Her educational foundation includes a B.Sc. from MIT and M.Sc./Ph.D. from the University of Massachusetts. This training underpins her cross-disciplinary approach integrating engineering, chemistry, and biology to address unmet medical needs. Shoichet's research centers on four synergistic pillars: (1) Targeted cancer delivery using colloidal drug aggregates for breast, brain, lung, and lymphoma; (2) Injectable hydrogels enabling sustained biomolecule release to the CNS for spinal cord/retinal repair; (3) 3D biomimetic scaffolds modeling disease microenvironments for drug screening; and (4) Cell delivery systems enhancing stem cell survival in blindness/stroke applications. Her lab emphasizes translational impact through commercialization efforts like AmacaThera. Analysis of her 2021-2025 publications reveals accelerating innovation in RNA delivery platforms, neural repair strategies, and disease-specific hydrogel systems, with strong emphasis on pulmonary delivery, stroke recovery mechanisms, and ocular therapeutics. These works bridge nanomedicine, regenerative biology, and clinical translation across cancer and neurological disorders. Her exceptional contributions are recognized through over 30 major honors including: Gerhard Herzberg Canada Gold Medal (2020) Killam Prize in Engineering (2017) Foreign Membership in US National Academy of Engineering (2016) Fellowship in The Royal Society (2019) Officer of the Order of Canada (2018) L’Oréal-UNESCO For Women in Science Laureate (2015) Shoichet actively mentors graduate students (including OGS/QEII scholars Chris Ling, Nadiyah Khan, and Riley Li) and secures major funding from Natural Sciences and Engineering Research Council (NSERC), Canadian Institutes of Health Research (CIHR), Canada First Research Excellence Fund (Medicine by Design), Krembil Foundation, and McEwen Foundation. Her lab operates as a multidisciplinary hub collaborating with stem cell biologists, neurosurgeons, and cancer researchers to advance therapeutic pipelines. The Shoichet Lab maintains state-of-the-art facilities for polymer synthesis, cell culture, and in vivo testing, with current projects focused on RNA delivery stabilization, glaucoma treatment systems, and stroke recovery mechanisms. Her TERMIS-Americas leadership and commercialization initiatives demonstrate commitment to translating biomaterials innovations into clinical impact.
Dr. Qian Zhong is an Assistant Professor in the Division of Molecular Pharmaceutics and Drug Delivery at the University of Texas at Austin's College of Pharmacy. His research focuses on engineering biomaterials for precision diagnostics and therapeutics, particularly in cancer and chronic pulmonary disorders. He holds a Ph.D. in Materials Science from Wayne State University and completed postdoctoral training in Radiology at Stanford University. Education: Ph.D. in Materials Science, Wayne State University (Advisor: Prof. Sandro da Rocha) Postdoctoral Fellow, Department of Radiology, Stanford University (Mentor: Prof. Raag Airan) Research Interests: Dr. Zhong develops modular biomaterials for disease biomarker profiling, noninvasive diagnostics, and targeted drug delivery. His lab focuses on: Inhalable biosensors for early cancer detection Ultrasound-responsive drug delivery systems Microenvironment-based therapeutic platforms Noninvasive delivery via pulmonary/nasal routes Publications highlight advancements in fusogenic lipid nanocarriers, point-of-care diagnostics, and CRISPR-amplified biomarkers. His work bridges diagnostics and therapy to enable personalized precision medicine. Labs/Teams: Zhong's lab at UT Austin integrates bioengineering, materials science, and clinical translation to advance noninvasive approaches for early disease detection and targeted therapy.
Tamara Stojmenović is a faculty member at Singidunum University within the Faculty of Physical Culture and Management in Sports . She holds a Doctor of Medicine degree from the University of Belgrade (2003-2010), a Specialist in Sports Medicine from the University of Belgrade (2014-2017), and a PhD in Experimental and Applied Physiology with Sports Medicine from the University of Kragujevac (2011-2019). Her research focuses on Sports Medicine , Physiology , and Cardiorespiratory Fitness , particularly examining: Cardiovascular responses to exercise Post-COVID-19 physiological impacts on athletes Physical activity optimization through ventilatory threshold analysis Comparative physiological profiles across sports disciplines Recent trends in her publications include athlete cardiac health, strain-specific SARS-CoV-2 effects, and injury prevention in basketball players. Her work appears in journals like Journal of Clinical Medicine , Diagnostics , and Medicina (Kaunas) , covering topics from maximal oxygen consumption to sports injury epidemiology. Professional Contributions: Co-author of two textbooks: Corrective gymnastics and kinesitherapy in sports (2021) and Sports medicine - through questions and answers (2020) Presented at multiple conferences on topics including ACL rupture prevention and athlete overtraining Conducts applied research on sports performance, physical activity prescription, and injury rehabilitation
